BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4821484)

  • 1. Rupture of the cervix in prostaglandin abortions.
    Kajanoja P; Jungner G; Widholm O; Karjalainen O; Seppälä M
    J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):242-4. PubMed ID: 4821484
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical priming before first trimester aspiration abortion: a single blind study comparing gemeprost 1 mg and prostaglandin E2 10 mg pessaries.
    Mackenzie IZ; Jackson C; Mckinlay E; Millar J
    J Obstet Gynaecol (Lahore); 1990 Oct; 10(6):513-7. PubMed ID: 12284145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of abortion by extra-ammiotic prostaglandin administration.
    Wiqvist N; Béguin F; Bygdeman M; Fernström I; Toppozada M
    Prostaglandins; 1972 Jan; 1(1):37-53. PubMed ID: 4660224
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of an intracervical prostaglandin E2 preparation, Cerviprost, on cervical ripening before first trimester abortion in nulliparous patients.
    Irvine LM; Shaw RW
    J Obstet Gynaecol (Lahore); 1989; 10(2):120-3. PubMed ID: 12283723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminaria augmentation of intra-amniotic prostaglandin F2 alpha for the induction of mid-trimester abortion.
    Brenner WE; Hendricks CH; Dingfelder J; Staurovsky L
    Prostaglandins; 1973 Jun; 3(6):879-94. PubMed ID: 4729606
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of the cervix with 9-deoxy-16,16-dimethyl-9-methylene-prostaglandin E2 (Meteneprost) vaginal pessaries before first trimester legal abortion in nulliparae.
    Nyholm HC; Mikkelsen AL; Secher NJ
    J Obstet Gynaecol (Lahore); 1988; 8(3):210-3. PubMed ID: 12342310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-amniotic prostaglandin F2 alpha to induce midtrimester abortion.
    Corson SL; Bolognese RJ; Merola J
    Am J Obstet Gynecol; 1973 Sep; 117(1):27-34. PubMed ID: 4722375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Rupture of uterus during prostaglandin-induced abortion.
    Smith AM
    Br Med J; 1975 Jan; 1(5951):205. PubMed ID: 1111746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: complications of prostaglandin-induced abortion.
    Amy JJ
    Br Med J; 1974 Dec; 4(5945):654. PubMed ID: 4441836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of abortion by intra- and extra-amniotic prostaglandin F2 administration.
    Järvinen PA; Pennanen S; Ylöstalo P
    Prostaglandins; 1973 Apr; 3(4):491-504. PubMed ID: 4729587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.
    Molin A
    Gynecol Obstet Invest; 1993; 35(3):152-4. PubMed ID: 8505006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical dilatation with pessaries containing a new prostaglandin E1 analogue in patients undergoing induced abortion.
    Nakano R
    Am J Obstet Gynecol; 1982 Dec; 144(7):862. PubMed ID: 7148915
    [No Abstract]   [Full Text] [Related]  

  • 15. Extraovular prostaglandin F2alpha for early midtrimester abortion.
    Shapiro AG
    Am J Obstet Gynecol; 1975 Feb; 121(3):333-6. PubMed ID: 1115147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective demonstration of cervical softening with a prostaglandin F2 alpha gel during first trimester abortion.
    Rath W; Kühnle H; Theobald P; Kuhn W
    Int J Gynaecol Obstet; 1982 Jun; 20(3):195-9. PubMed ID: 6127245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity risk among young adolescents undergoing elective abortion.
    Burkman RT; Atienza MF; King TM
    Contraception; 1984 Aug; 30(2):99-105. PubMed ID: 6499441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The abortifacient action of the extraovular "prostaglandin impact" during the first half of human pregnancy.
    Enkola K
    Prostaglandins; 1974 Jan; 5(1):115-21. PubMed ID: 4816714
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaginally administered PGF2alpha for cervical dilatation in nulliparas prior to suction curettage.
    Brenner WE; Dingfelder JR; Staurovsky LG; Hendricks CH
    Prostaglandins; 1973 Dec; 4(6):819-36. PubMed ID: 4783581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.